- Home
- AUTL vs AXGN Comparison
AUTL vs AXGN Comparison
Compare AUTL & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- AXGN
- Stock Information
- Founded
- AUTL 2014
- AXGN N/A
- Country
- AUTL United Kingdom
- AXGN United States
- Employees
- AUTL N/A
- AXGN N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AUTL Health Care
- AXGN Health Care
- Exchange
- AUTL Nasdaq
- AXGN Nasdaq
- Market Cap
- AUTL 625.4M
- AXGN 538.3M
- IPO Year
- AUTL 2018
- AXGN N/A
- Fundamental
- Price
- AUTL $2.31
- AXGN $10.47
- Analyst Decision
- AUTL Strong Buy
- AXGN Strong Buy
- Analyst Count
- AUTL 5
- AXGN 6
- Target Price
- AUTL $9.32
- AXGN $23.83
- AVG Volume (30 Days)
- AUTL 2.4M
- AXGN 569.4K
- Earning Date
- AUTL 08-07-2025
- AXGN 08-07-2025
- Dividend Yield
- AUTL N/A
- AXGN N/A
- EPS Growth
- AUTL N/A
- AXGN N/A
- EPS
- AUTL N/A
- AXGN N/A
- Revenue
- AUTL $9,011,000.00
- AXGN $194,520,000.00
- Revenue This Year
- AUTL $461.76
- AXGN $18.08
- Revenue Next Year
- AUTL $112.66
- AXGN $16.15
- P/E Ratio
- AUTL N/A
- AXGN N/A
- Revenue Growth
- AUTL N/A
- AXGN 18.81
- 52 Week Low
- AUTL $1.11
- AXGN $7.09
- 52 Week High
- AUTL $5.00
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- AUTL 69.32
- AXGN 44.20
- Support Level
- AUTL $1.98
- AXGN $9.35
- Resistance Level
- AUTL $2.10
- AXGN $10.40
- Average True Range (ATR)
- AUTL 0.13
- AXGN 0.50
- MACD
- AUTL -0.00
- AXGN 0.19
- Stochastic Oscillator
- AUTL 73.63
- AXGN 61.88
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.